Hedgehog pathway inhibitors are used to treat basal cell carcinoma and acute myeloid leukemia. These medications work by blocking an overactive Hedgehog signaling pathway, which is involved in the growth and spread of cancer cells. Hedgehog pathway inhibitors are available in oral forms. Examples include Daurismo (glasdegib), Erivedge (vismodegib), and Odomzo (sonidegib).